{"id":2158,"date":"2023-08-03T13:50:18","date_gmt":"2023-08-03T11:50:18","guid":{"rendered":"https:\/\/semmelweis.hu\/tmk\/?page_id=2158"},"modified":"2025-02-21T13:04:11","modified_gmt":"2025-02-21T12:04:11","slug":"yi-xu","status":"publish","type":"post","link":"https:\/\/semmelweis.hu\/tmk\/2023\/08\/03\/yi-xu\/","title":{"rendered":"Yi Xu"},"content":{"rendered":"<div style=\"margin-bottom: 20px\">\n<div style=\"font-size: 1em;font-weight: bold;color: #232F61;margin-bottom: 5px\">TOPIC<\/div>\n<p>    <span style=\"font-size: 0.9em;color: #424a52\">Therapy Predictive Markers in Urothelial Carcinoma<\/span>\n<\/div>\n<div style=\"margin-bottom: 20px\">\n<div style=\"font-size: 1em;font-weight: bold;color: #232F61;margin-bottom: 5px\">VISION<\/div>\n<p>    <span style=\"font-size: 0.9em;color: #424a52\">Deliver scientifically empowered practice &amp; care for cancer patients.<\/span>\n<\/div>\n<div style=\"margin-bottom: 20px\">\n<div style=\"font-size: 1em;font-weight: bold;color: #232F61;margin-bottom: 5px\">MISSION<\/div>\n<p>    <span style=\"font-size: 0.9em;color: #424a52\">Extract best evidence from clinical &amp; laboratory data through critical appraisal &amp; evaluation.<\/span>\n<\/div>\n<div style=\"margin-bottom: 20px\">\n<div style=\"font-size: 1em;font-weight: bold;color: #232F61;margin-bottom: 5px\">SPECIFIC GOALS<\/div>\n<p>    <span style=\"font-size: 0.9em;color: #424a52\"><strong>PROJECT 1:<\/strong> Investigating Therapy Predictive Markers in Patients with Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis.<\/span>\n<\/div>\n<div style=\"margin-bottom: 20px\">\n    <span style=\"font-size: 0.9em;color: #424a52\"><strong>PROJECT 2:<\/strong> Updates on Previous Meta-Analysis of the Management of Urachal Carcinoma: A Systematic Review and Meta-analysis.<\/span>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>TOPIC Therapy Predictive Markers in Urothelial Carcinoma VISION Deliver scientifically empowered practice &amp; care for cancer patients. MISSION Extract best evidence from clinical &amp; laboratory data through critical appraisal &amp; evaluation. SPECIFIC GOALS PROJECT 1: Investigating Therapy Predictive Markers in Patients with Urothelial Carcinoma Receiving Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis. PROJECT 2: &hellip;<\/p>\n","protected":false},"author":101929,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[7],"tags":[10],"class_list":["post-2158","post","type-post","status-publish","format-standard","hentry","category-phd-hallgato","tag-gynecology-urology"],"acf":[],"_links":{"self":[{"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/posts\/2158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/users\/101929"}],"replies":[{"embeddable":true,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/comments?post=2158"}],"version-history":[{"count":6,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/posts\/2158\/revisions"}],"predecessor-version":[{"id":4469,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/posts\/2158\/revisions\/4469"}],"wp:attachment":[{"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/media?parent=2158"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/categories?post=2158"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/semmelweis.hu\/tmk\/wp-json\/wp\/v2\/tags?post=2158"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}